Patents Represented by Attorney, Agent or Law Firm Karen Kendrad
  • Estrogen receptor-&bgr; ligands
    Patent number: 6518301
    Abstract: A method for treating a disease associated with the estrogen receptor-&bgr;, comprising the step of administering a therapeutically-effective amount of a compound that satisfies the equation: (Ki&agr;A/Ki&bgr;A)/(Ki&agr;E/Ki&bgr;E)>1, optionally having the general structure (I).
    Type: Grant
    Filed: January 7, 2002
    Date of Patent: February 11, 2003
    Assignee: AstraZeneca AB
    Inventors: Bernard Christophe Barlaam, Timothy Martin Piser